Who Paid My Doc
enVista MX60 IOL
Device Ophthalmology
PDI 10757770541062
General payments
$2,052,404
Research payments
$2,630,255
Through program year 2025, $2,052,404 in general payments and $2,630,255 in research payments were reported against enVista MX60 IOL (Ophthalmology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $266,000 | 317 |
| 2025 | Research | $36,809 | 4 |
| 2024 | General | $730,815 | 1,492 |
| 2024 | Research | $66,072 | 10 |
| 2023 | General | $638,859 | 2,708 |
| 2023 | Research | $936,659 | 88 |
| 2022 | General | $416,730 | 2,662 |
| 2022 | Research | $1,590,716 | 75 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 29 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
7,179 general · 177 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.